VP – Commercial Development – Secure series A funding round and accelerate commercialisation
Taragenyx is a pioneering start-up in the field of restorative implant solutions for the orthopaedic and dental markets.
The company has developed a patented technology that is set to bring significant benefits to patients in this £15bn global market and has already received support from market leading organisations.
Based in Glasgow and established in 2012 by experienced industry executives, Taragenyx had secured significant investment that enabled the expansion of the team and the commencement of trials. The revenue model challenges the norm through early commercial wins, creating scope to grow a global organisation and build a new future in healthcare.
With fundraising about to get underway for a $7m series A round, the business was looking to grow its highly entrepreneurial team; with the objective of bringing the dynamism of a tech start-up to a medtech business by attracting eminently credible and successful individuals from the world of healthcare.
The next phase of that strategy was for Taragenyx to appoint a world-class VP Commercial Development with a suitably strong track record in customer development and dealmaking to accelerate the commercialisation of their products and maximize the long-term success of the company’s future pipeline.